FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2985139441> ?p ?o ?g. }

• W2985139441 endingPage "1333" @default.
• W2985139441 startingPage "1313" @default.
• W2985139441 abstract "Mushrooms are well-known to possess a continuum of anticancer metabolites that are vital in the development of anticancer adjuvant drug leads based on natural products. Owing to the fact that conventional cancer therapeutic methods were failed to lessen mortality caused by cancer to the estimated level with occurrence of adverse side effects, anticancer agents isolated from natural mushroom sources unarguably make an experimental research area worth mass focus today. The current study was targeted on in vitro cytotoxicity and in silico predictive pharmacological analysis of a flavonoid compound isolated from Fulvifomes fastuosus mushroom. Targeted compound was isolated from the mushroom using different chromatographic methods and identified by NMR spectrometry and mass spectrometry. Cytotoxicity experiments were carried out using MTT assay and apoptotic cells were identified by ethidium bromide/acridine orange staining. The SwissADME tool, BOILED-Egg construction model and Swiss target protein prediction software have been used to perform in silico predictive pharmacological analysis. The isolated compound has been identified as 2-(3,4-dihydroxyphenyl)-6-[(E)-2-(3,4-dihydroxyphenyl)ethenyl]-5'-methylspiro[2H-furo[3,2-c]pyran-3,2'-furan]-3',4-dione by spectrometric methods. The result of MTT assay showed that 2-(3,4-dihydroxyphenyl)-6-[(E)-2-(3,4-dihydroxyphenyl)ethenyl]-5'-methylspiro[2H-furo[3,2-c]pyran-3,2'-furan]-3',4-dione has potent anticancer activity for hepatoma against Hep-G2 cell line (IC50 = 20.8 μg/ml) being less toxic to normal CC-1 epithelial cells (IC50 = 167.00 μM). The cells treated with compound ex-hibited apoptotic features such as cellular shrinkage, nuclear fragmentation and condensed cytoplasm. In summary, 2-(3,4-dihydroxyphenyl)-6-[(E)-2-(3,4-dihydroxyphenyl)ethenyl]-5'-methylspiro[2H-furo[3,2-c]pyran-3,2'-furan]-3',4-dione has shown potent anticancer properties against hepatoma with less cytotoxicity effect on normal cells. Furthermore, in silico study has revealed that properties of 2-(3,4-dihydroxyphenyl)-6-[(E)-2-(3,4-dihydroxyphenyl)ethenyl]-5'-methylspiro[2H-furo[3,2-c]pyran-3,2'-furan]-3',4-dione may contribute to making a high absorption and clearance of the test compound as not interfering with the therapeutic failure of the compound. The properties of 2-(3,4-dihydroxyphenyl)-6-[(E)-2-(3,4-dihydroxyphenyl)ethenyl]-5'-methylspiro[2H-furo-[3,2-c]pyran-3,2'-furan]-3',4-dione were compatible with well-known anticancer drug lapatinib. In conclusion, 2-(3,4-dihydroxyphenyl)-6-[(E)-2-(3,4-dihydroxyphenyl)ethenyl]-5'-methylspiro[2H-furo[3,2-c]pyran-3,2'-furan]-3',4-dione has a high tendency to act as a good anticancer adjuvant drug in the treatment of hepatoma." @default.
• W2985139441 created "2019-11-22" @default.
• W2985139441 creator A5003589862 @default.
• W2985139441 creator A5020086161 @default.
• W2985139441 creator A5036683192 @default.
• W2985139441 creator A5042148028 @default.
• W2985139441 creator A5054989882 @default.
• W2985139441 creator A5055859731 @default.
• W2985139441 creator A5068357319 @default.
• W2985139441 creator A5081965732 @default.
• W2985139441 date "2019-01-01" @default.
• W2985139441 modified "2023-10-16" @default.
• W2985139441 title "&lt;i&gt;In Silico&lt;/i&gt; Pharmacological Analysis of a Potent Anti-Hepatoma Compound of Mushroom Origin and Emerging Role as an Adjuvant Drug Lead" @default.
• W2985139441 cites W1527820925 @default.
• W2985139441 cites W1964053173 @default.
• W2985139441 cites W1986023617 @default.
• W2985139441 cites W1987612487 @default.
• W2985139441 cites W1993107931 @default.
• W2985139441 cites W1997362383 @default.
• W2985139441 cites W1997872760 @default.
• W2985139441 cites W1999124243 @default.
• W2985139441 cites W2010915182 @default.
• W2985139441 cites W2016421716 @default.
• W2985139441 cites W2023050422 @default.
• W2985139441 cites W2030711777 @default.
• W2985139441 cites W2068790232 @default.
• W2985139441 cites W2135732933 @default.
• W2985139441 cites W2148551738 @default.
• W2985139441 cites W2158764247 @default.
• W2985139441 cites W2225235469 @default.
• W2985139441 cites W2401677822 @default.
• W2985139441 cites W2516556632 @default.
• W2985139441 cites W2593436234 @default.
• W2985139441 cites W2751729077 @default.
• W2985139441 cites W3175318380 @default.
• W2985139441 cites W4253413107 @default.
• W2985139441 doi "https://doi.org/10.4236/fns.2019.1011095" @default.
• W2985139441 hasPublicationYear "2019" @default.
• W2985139441 type Work @default.
• W2985139441 sameAs 2985139441 @default.
• W2985139441 citedByCount "3" @default.
• W2985139441 countsByYear W29851394412021 @default.
• W2985139441 countsByYear W29851394412023 @default.
• W2985139441 crossrefType "journal-article" @default.
• W2985139441 hasAuthorship W2985139441A5003589862 @default.
• W2985139441 hasAuthorship W2985139441A5020086161 @default.
• W2985139441 hasAuthorship W2985139441A5036683192 @default.
• W2985139441 hasAuthorship W2985139441A5042148028 @default.
• W2985139441 hasAuthorship W2985139441A5054989882 @default.
• W2985139441 hasAuthorship W2985139441A5055859731 @default.
• W2985139441 hasAuthorship W2985139441A5068357319 @default.
• W2985139441 hasAuthorship W2985139441A5081965732 @default.
• W2985139441 hasBestOaLocation W29851394411 @default.
• W2985139441 hasConcept C104317684 @default.
• W2985139441 hasConcept C109316439 @default.
• W2985139441 hasConcept C185592680 @default.
• W2985139441 hasConcept C190283241 @default.
• W2985139441 hasConcept C202751555 @default.
• W2985139441 hasConcept C2775905019 @default.
• W2985139441 hasConcept C2776907736 @default.
• W2985139441 hasConcept C2777752497 @default.
• W2985139441 hasConcept C2779102032 @default.
• W2985139441 hasConcept C2780783641 @default.
• W2985139441 hasConcept C552990157 @default.
• W2985139441 hasConcept C55493867 @default.
• W2985139441 hasConcept C71240020 @default.
• W2985139441 hasConcept C86803240 @default.
• W2985139441 hasConcept C98274493 @default.
• W2985139441 hasConceptScore W2985139441C104317684 @default.
• W2985139441 hasConceptScore W2985139441C109316439 @default.
• W2985139441 hasConceptScore W2985139441C185592680 @default.
• W2985139441 hasConceptScore W2985139441C190283241 @default.
• W2985139441 hasConceptScore W2985139441C202751555 @default.
• W2985139441 hasConceptScore W2985139441C2775905019 @default.
• W2985139441 hasConceptScore W2985139441C2776907736 @default.
• W2985139441 hasConceptScore W2985139441C2777752497 @default.
• W2985139441 hasConceptScore W2985139441C2779102032 @default.
• W2985139441 hasConceptScore W2985139441C2780783641 @default.
• W2985139441 hasConceptScore W2985139441C552990157 @default.
• W2985139441 hasConceptScore W2985139441C55493867 @default.
• W2985139441 hasConceptScore W2985139441C71240020 @default.
• W2985139441 hasConceptScore W2985139441C86803240 @default.
• W2985139441 hasConceptScore W2985139441C98274493 @default.
• W2985139441 hasIssue "11" @default.
• W2985139441 hasLocation W29851394411 @default.
• W2985139441 hasOpenAccess W2985139441 @default.
• W2985139441 hasPrimaryLocation W29851394411 @default.
• W2985139441 hasRelatedWork W1971344799 @default.
• W2985139441 hasRelatedWork W2003061036 @default.
• W2985139441 hasRelatedWork W2011715609 @default.
• W2985139441 hasRelatedWork W2069757250 @default.
• W2985139441 hasRelatedWork W2071597726 @default.
• W2985139441 hasRelatedWork W2611332634 @default.
• W2985139441 hasRelatedWork W2736106693 @default.
• W2985139441 hasRelatedWork W4307573441 @default.
• W2985139441 hasRelatedWork W4384283615 @default.
• W2985139441 hasRelatedWork W2560330146 @default.
• W2985139441 hasVolume "10" @default.

• next